Ketoconazole in Cushing’s syndrome: a profile of its use
Ketoconazole in Cushing’s syndrome: a profile of its use
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Ketoconazole (Ketoconazole HRA™), an imidazole derivative, is a useful treatment option in the management of endogenous Cushing’s syndrome in adults and adolescents > 12 years of age, based on evidence from more than three decades of use of the drug in clinical practice. Originally developed as an antifungal agent, ketoconazole is a potent steroido...
Alternative Titles
Full title
Ketoconazole in Cushing’s syndrome: a profile of its use
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2499456690
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2499456690
Other Identifiers
ISSN
1172-0360
E-ISSN
1179-1977
DOI
10.1007/s40267-020-00799-7
